OpenURL Connection Search

Select item for more details and to access through your institution.

Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical Trial.
Published in:
2020
By:
- Atalay, Selma;
- van den Reek, Juul M. P. A.;
- den Broeder, Alfons A.;
- van Vugt, Lieke J.;
- Otero, Marisol E.;
- Njoo, Marcellus D.;
- Mommers, Johannes M.;
- Ossenkoppele, Paul M.;
- Koetsier, Marjolein I.;
- Berends, Maartje A.;
- van de Kerkhof, Peter C. M.;
- Groenewoud, Hans M. M.;
- Kievit, Wietske;
- de Jong, Elke M. G. J.
Publication type:
journal article
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.
Published in:
American Journal of Clinical Dermatology, 2024, v. 25, n. 4, p. 685, doi. 10.1007/s40257-024-00868-x
By:
- Thomas, Sarah E.;
- Seyger, Marieke M. B.;
- Mangnus, Josje E.;
- Otero, Marisol E.;
- Gostynski, Antoni H.;
- Njoo, Marcellus D.;
- Ossenkoppele, Paul M.;
- Haeck, Inge M.;
- Hendricksen-Roelofzen, Judith H. J.;
- Körver, John E. M.;
- Dodemont, Sharon R. P.;
- Tupker, Ron A.;
- Berends, Maartje A. M.;
- Weppner-Parren, Lizelotte M. J. T.;
- Keijsers, Romy R. M. C.;
- Oostveen, Annet M.;
- Peters, Bas;
- Mommers, Roland;
- van Doorn, Martijn B. A.;
- Tjioe, Milan
Publication type:
Article
Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort.
Published in:
Acta Dermato-Venereologica, 2022, v. 102, p. 1, doi. 10.2340/actadv.v102.206
By:
- VAN MUIJEN, Marloes E.;
- THOMAS, Sarah E.;
- GROENEWOUD, Hans M. M.;
- OTERO, Marisol E.;
- OSSENKOPPELE, Paul M.;
- NJOO, Marcellus D.;
- DODEMONT, Sharon R. P.;
- KOP, Else N.;
- BERENDS, Maartje A. M.;
- KOETSIER, Marjolein I. A.;
- MOMMERS, Johannes M.;
- KÖRVER, John E. M.;
- TUPKER, Ron A.;
- DE BRUIN-WELLER, Marjolein S.;
- WEPPNERPARREN, Lizelotte J. M. T.;
- PETERS, Bas;
- KLEINPENNING, Marloes M.;
- KUIJPERS, Astrid L. A.;
- ARNOLD, W. Peter;
- VAN LÜMIG, Paula P. M.
Publication type:
Article
Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study.
Published in:
Acta Dermato-Venereologica, 2020, v. 100, n. 12, p. 1, doi. 10.2340/00015555-3692
By:
- ATALAY, Selma;
- VAN DEN REEK, Juul M. P. A.;
- OTERO, Marisol E.;
- NJOO, Marcellus D.;
- MOMMERS, Johannes M.;
- OSSENKOPPELE, Paul M.;
- KOETSIER, Marjolein I.;
- BERENDS, Maartje A.;
- VAN DE KERKHOF, Peter C. M.;
- GROENEWOUD, Hans M. M.;
- DEN BROEDER, Alfons A.;
- DE JONG, Elke M. G. J.;
- KIEVIT, Wietske
Publication type:
Article
Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study.
Published in:
Acta Dermato-Venereologica, 2018, v. 98, n. 7, p. 648, doi. 10.2340/00015555-2900
By:
- VAN DEN REEK, Juul M. P. A.;
- VAN VUGT, Lieke J.;
- VAN DOORN°, Martijn B. A.;
- VAN DER KRAAIJ°, Gayle E.;
- DE KORT, Wim J. A.;
- LUCKER, Georges P. H.;
- HORVATH, Barbara;
- NJOO, M. David;
- BOVENSCHEN, H. Jorn;
- OSSENKOPPELE, Paul M.;
- DE BRUIN-WELLER, Marjolein S.;
- DE GROOT, Marjan;
- MOMMERS, Roland;
- PREVOO, Ruud L. M. A.;
- VAN DE KERKHOF, Peter C. M.;
- SPULS, Phyllis I.;
- KIEVIT, Wietske;
- DE JONG, Elke M. G. J.
Publication type:
Article

Found: 5

Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical Trial.

Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.

Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort.

Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study.

Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study.